Samuel Rivera
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Inflammatory Biomarkers in Disease Prognosis
- Surgery top 10%
- Bladder and Urothelial Cancer Treatments
Papers in
-
- Parasites and Host Interactions 1
-
- Thyroid Cancer Diagnosis and Treatment 1
- Co-authors
- Luis A. Balart (1 shared paper)Alba Bergas (1 shared paper)Francisco Javier Martín‐Sánchez (1 shared paper)Juan María González del Castillo (1 shared paper)Óscar Moreno (1 shared paper)Pere Llorens‐Soriano (1 shared paper)Adrián Valls Carbó (1 shared paper)Begoña Espinosa (1 shared paper)
- Journals
- The Lancet Oncology (1 paper)The American Journal of Gastroenterology (1 paper)Gaceta Mexicana de Oncología (1 paper)Journal of Healthcare Quality Research (1 paper)Enfermedades infecciosas y microbiologia clinica (English ed ) (1 paper)
- Partner nations
- SpainUnited StatesMexico
In The Last Decade
Samuel Rivera
4 papers receiving 406 citations
Samuel Rivera's Hit Papers
Peers
Comparison fields: 5 of 28
- Oncology 177
- Surgery 248
- Statistics and Probability 10
- Hepatology 3
- Nephrology 3
Countries citing papers authored by Samuel Rivera
This map shows the geographic impact of Samuel Rivera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Rivera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Rivera more than expected).
Fields of papers citing papers by Samuel Rivera
This network shows the impact of papers produced by Samuel Rivera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Rivera. The network helps show where Samuel Rivera may publish in the future.
Co-authors
The 15 scholars most cited alongside Samuel Rivera, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial Hit paper breakdown → | 2020 | 408 |
| 2 | 2022 | 2 | |
| 3 | 2006 | 1 | |
| 4 | 2022 | 1 | |
| 5 | 2019 | 0 |
About Samuel Rivera
Samuel Rivera is a scholar working on Parasitology, Endocrinology, Diabetes and Metabolism, Infectious Diseases, Epidemiology and Surgery, having authored 5 papers that have together received 412 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (1 paper), Parasites and Host Interactions (1 paper), Thyroid Cancer Diagnosis and Treatment (1 paper), COVID-19 Clinical Research Studies (1 paper) and Infective Endocarditis Diagnosis and Management (1 paper). The work is most often cited by research in Oncology (177 citations), Surgery (248 citations), Statistics and Probability (10 citations), Hepatology (3 citations) and Nephrology (3 citations). Samuel Rivera has collaborated with scholars based in Spain, United States and Mexico. Frequent co-authors include Luis A. Balart, Alba Bergas, Francisco Javier Martín‐Sánchez, Juan María González del Castillo, Óscar Moreno, Pere Llorens‐Soriano, Adrián Valls Carbó, Begoña Espinosa, Óscar Murillo and Isabel Cirera. Their work appears in journals such as The Lancet Oncology, The American Journal of Gastroenterology, Gaceta Mexicana de Oncología, Journal of Healthcare Quality Research and Enfermedades infecciosas y microbiologia clinica (English ed ).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.